Fillet Georges

JASPERS, A., Baron, F., Maertens, J., DE PRIJCK, B., Schots, R., Bonnet, C., HAFRAOUI, K., WILLEMS, E., SERVAIS, S., FILLET, G., & Beguin, Y. (July 2015). Long-term safety follow-up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantation [letter to the editor]. American Journal of Hematology, 90 (7), 133-4. doi:10.1002/ajh.24013

JASPERS, A., BARON, F., MAERTENS, J., DE PRIJCK, B., SCHOTS, H., BONNET, C., HAFRAOUI, K., WILLEMS, E., SERVAIS, S., FILLET, G., & BEGUIN, Y. (December 2014). Long-term safety follow-up of a rendomized trial of Darbepoetin Alpha and intravenous iron following autologous hematopoietic cell transplantation. Blood, 124 (21), 3948.

Willemze, R., Suciu, S., Meloni, G., Labar, B., Marie, J.-P., Halkes, C., Muus, P., Mistrik, M., Amadori, S., Specchia, G., Fabbiano, F., Nobile, F., Sborgia, M., Camera, A., Selleslag, D., Lefrère, F., Magro, D., Sica, S., Cantore, N., ... de Witte, T. (2014). High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 Trial. Journal of Clinical Oncology, 32 (3), 219-228. doi:10.1200/JCO.2013.51.8571

JASPERS, A., CAERS, J., LE GAC, G., FEREC, C., BEGUIN, Y., & FILLET, G. (February 2013). A novel mutation in the CUB sequence of matriptase-2 (TMPRSS6) is implicated in iron-resistant iron deficiency anaemia (IRIDA). British Journal of Haematology, 160 (4), 564-565. doi:10.1111/bjh.12147

BEGUIN, Y., Maertens, J., DE PRIJCK, B., Schots, R., Seidel, L., BONNET, C., HAFRAOUI, K., WILLEMS, E., Vanstraelen, G., SERVAIS, S., JASPERS, A., FILLET, G., & BARON, F. (2013). Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation : A prospective multicenter randomized trial. American Journal of Hematology, 88, 990-996. doi:10.1002/ajh.23552

de Leval, L., BONNET, C., Copie-Bergman, C., SEIDEL, L., Baia, M., Brière, J., Molina, T., Fabiani, B., Petrella, T., Bosq, J., Gisselbrecht, C., Siebert, R., Tilly, H., Haioun, C., Fillet, G., & Gaulard, P. (2012). Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study. Annals of Oncology. doi:10.1093/annonc/mds150

de Leval, L., Bonnet, C., Copie-Bergman, C., Seidel, L., Baia, M., Brière, J., Molina, T. J., Fabiani, B., Petrella, T., Bosq, J., Gisselbrecht, C., Siebert, R., Tilly, H., Haioun, C., Fillet, G., & Gaulard, P. (2012). Diffuse large B-cell lymphoma of Waldeyer's ring has distinc clinicopathologic features: a GELA study. Annals of Oncology, 23(12), 3143-3151.

Thielen, C., Bisig, B., Gofflot, S., Herens, C., Fillet, G., JAMAR, M., Tassin, F., Boniver, J., Drion, P., & de Leval, L. (2011). CHIC cells: a novel ALK+ cell line derived from a relapsed anaplastic large cell lymphoma. British Journal of Haematology, 152, 356-360. doi:10.1111/j.1365-2141.2010.08414.x

Willems, E.* , Baron, F.* , Seidel, L., Frère, P., Fillet, G., & Beguin, Y. (2010). Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning. Bone Marrow Transplantation, 45, 689-693. doi:10.1038/bmt.2009.230

Baron, F., Lechanteur, C., Willems, E., Bruck, F., Baudoux, E., Seidel, L., Vanbellinghen, J.-F., Hafraoui, K., LEJEUNE, M., Gothot, A., Fillet, G., & Beguin, Y. (2010). Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning. Biology of Blood and Marrow Transplantation, 16 (6), 838-47. doi:10.1016/j.bbmt.2010.01.011

Labar, B., Suciu, S., Willemze, R., Muus, P., Marie, J. P., Fillet, G., Berneman, Z., Jaksic, B., Feremans, W., Bron, D., Sinnige, H., Mistrik, M., Vreugdenhil, G., de Bock, R., Nemet, D., Gilotay, C., Amadori, S., & De Witte, T. (2010). Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma : final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group. Haematologica, 95, 1489-1495. doi:10.3324/haematol.2009.018580

Collignon, J., Gennigens, C., Rorive, A., Coucke, P., Lifrange, E., Maweja, S., Fillet, G., & Jerusalem, G. (May 2009). ANTICORPS MONOCLONAUX ET CANCER DU SEIN: Actualités thérapeutiques. Revue Médicale de Liège, 64 (5-6), 279-83.

Bonnet, C., Beguin, Y., De Prijck, B., de Leval, L., & Fillet, G. (2009). Traitements actuels du lymphome folliculaire. Revue Médicale Suisse, 5, 1663-7.

Bonnet, C., Beguin, Y., De Prijck, B., Witvrouw, N., Hustinx, R., & Fillet, G. (2009). Les anticorps monoclonaux en hématologie en 2009. Revue Médicale de Liège, 64, 268-273.

Beguin, Y., Maertens, J., DE PRIJCK, B., Schots, R., Frère, P., Bonnet, C., HAFRAOUI, K., WILLEMS, E., Vanstraelen, G., LEJEUNE, M., SERVAIS, S., THeunissen, K., Fillet, G., & Baron, F. (2009). A prospective randomized multicenter trial of darbepoetin-alfa and I.V. iron administration after autologous hematopoietic stem cell transplantation [Poster presentation]. 24th General Meeting of the Belgian Hematological Society, Oostende, Belgium.

Baron, F., WILLEMS, E., LECHANTEUR, C., BAUDOUX, E., Frere, P., Vanbellinghen, J., Bruck, F., Gothot, A., HAFRAOUI, K., Fillet, G., & Beguin, Y. (2009). Co-transplantation of mesenchymal stem cells might mitigate acute GvHD without abrogating graftversus- tumour alloreactivity after allogeneic transplantation with non-myeloablative conditioning [Paper presentation]. 35th EBMT Annual Meeting.

Mievis, C., Jansen, N., Schleich, F., Gennigens, C., Rorive, A., Jerusalem, G., Fillet, G., & Sautois, B. (2009). Le cas clinique du mois. Reaction de rappel d'irradiation induite par l'administration de cyclophosphamide. Revue Médicale de Liège, 64 (4), 179-81.

Hafraoui, K., Moutschen, M., Smet, J., Mascart, F., Schaaf-Lafontaine, N., & Fillet, G. (2009). Selective defect of anti-pneumococcal IgG in a patient with persistent polyclonal B cell lymphocytosis. European Journal of Internal Medicine, 20 (3), 62-5. doi:10.1016/j.ejim.2008.08.005

Willems, E.* , Baron, F.* , Baudoux, E., Wanten, N., Seidel, L., Vanbellinghen, J.-F., Herens, C., Gothot, A., Frere, P., Bonnet, C., Hafraoui, K., Vanstraelen, G., Fillet, G., & Beguin, Y. (2009). Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial. Leukemia, 23 (3), 608-10. doi:10.1038/leu.2008.248

Lejeune, M., Beguin, Y., De Prijck, B., Fassotte, M.-F., Fillet, G., & Baron, F. (2008). Comment je traite...La leucémie myéloblastique aiguë (LMA) du sujet age en bon état général. Revue Médicale de Liège, 63 (2), 59-63.

Coudert, B., Focan, C., Genet, D., Giacchetti, S., Cvickovic, F., Zambelli, A., Fillet, G., Chollet, P., Amoroso, D., Van Der Auwera, J., Lentz, M. A., Marreaud, S., Baron, B., Gorlia, T., Biville, F., & Lévi, F. (2008). A randomized multicenter study of optimal circadian time of vinorelbine combined with chronomodulated 5-fluorouracil in pretreated metastatic breast cancer patients : eortc trial 05971. Chronobiology International, 25, 680-696. doi:10.1080/07420520802384036

de Leval, L., Bonnet, C., Brière, J., Molina, T., Petrella, T., Bosq, J., Falini, B., Gisselbrecht, C., Reyes, F., Fillet, G., & Gaulard, P. (2008). Diffuse large B-cell lymphoma (DLBCL) of the waldeyer'ring (WR) frequently have a GC-like phenotype: a clinico-pathological study of 209 patients from the groupe d'étude des lymphomes de l'adulte (GELA). Annals of Oncology, 13(suppl 4), 366.

Coucke, P., Barthelemy, N., Hustinx, R., & Fillet, G. (2008). Risk adaptive treatment in Hodgkin's lympoma: reduction of radiation dose and irradiated volume. Belgian Journal of Medical Oncology, 2 (2), 85-97.

Paulus, A., Gennigens, C., Fillet, G., Loly, C., & Sautois, B. (September 2007). Traitement chimiothérapique actuel du cancer de l'ovaire. Revue Médicale de Liège, 62 (9), 539-47.

Bonnet, C., Fillet, G., Mounier, N., Ganem, G., Molina, T. J., Thieblemont, C., Ferme, C., Quesnel, B., Brassiene, C., Gisselbrecht, C., Tilly, H., & Reyes, F. (01 March 2007). CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: A study by the Groupe d'Etude des Lymphomes de I'Adulte. Journal of Clinical Oncology, 25 (7), 787-792. doi:10.1200/JCO.2006.07.0722

de Leval, L., Bonnet, C., Copie-Bergman, C., Seidel, L., Baia, M., Brière, J., Molina, T., Fabiani, B., Falini, B., Gisselbrecht, C., Thilly, H., Albert, A., Fillet, G., & Gaulard, P. (2007). Diffuse large B-cell lymphomas of the waldeyer's ring frequently have a germinal center-like phenotype: a clinico-pathological study of 209 patients from the groupe d'étude des lymphomes de l'adulte (GELA). Annual Meeting Abstracts, 110, 1561.

Labar, B., Suciu, S., Muus, P., Willemze, R., Marie, J. P., Fillet, G., Berneman, Z., Jaksic, B., Feremans, W., Bron, D., Sinnige, H., Mistrik, M., Vreugdenhil, G., De Bock, R., Nemet, D., Gilotay, C., Amadori, S., & de Witte, T. (2007). Stem cell transplantation in ALL : a donor versus no donor comparison in the EORTC ALL-4 study. Leukemia Research. doi:10.1016/S0145-2126(07)70272-2

De Prijck, B., Baron, F., Beguin, Y., Bonnet, C., Willems, E., & Fillet, G. (2007). Actualités thérapeutiques en hématologie. Revue Médicale de Liège, 62 (5-6), 384-90.

Bonnet, C., & Fillet, G. (2007). How can we determine the role of radiotherapy in the treatment of localized aggressive non Hodgkin's lymphoma? Journal of Clinical Oncology, 25/n°19, 2857-2858.

de Leval, L., Bonnet, C., Copie-Bergmann, C., Seidel, L., Brière, J., Molina, T., Fabiani, B., Brunangelo, F., Gisselbrecht, C., Thilly, H., Albert, A., Fillet, G., & Gaulard, P. (2007). Diffuse Large B-cell Lymphomas of the waldeyer's ring frequently have a germinal center-like phenotype: a clinico-pathological study of 209 patients from the groupe d'étude des lymphomes de l'adulte (GELA). Blood.

Gennigens, C., Sautois, B., Rorive, A., Fillet, G., & Jerusalem, G. (2007). Actualites therapeutiques en oncologie: l'essor des therapeutiques ciblees. Revue Médicale de Liège, 62 (5-6, May-Jun), 391-8.

Jerusalem, G., Rorive, A., Gennigens, C., Sautois, B., Mievis, C., & Fillet, G. (2007). Actualités thérapeutiques en oncologie sénologique: place actuelle et perspectives des traitements cibles. Revue Médicale de Liège, 62 Spec No, 2-5.

Monville, J.-F., Fillet, G., & Ghaye, B. (2007). Thoracic Extramedullary Hematopoiesis Secondary to Enzymatic Deficiency. JBR-BTR, 90 (3, May-Jun), 198-9.

Bonnet, C., Beguin, Y., Fassotte, M.-F., Seidel, L., Luyckx, F., & Fillet, G. (2007). Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma. European Journal of Haematology, 78 (5), 399-404. doi:10.1111/j.1600-0609.2007.00843.x

Jerusalem, G., Silvestre, R., Beguin, Y., Hustinx, R., Fassotte, M.-F., & Fillet, G. (20 June 2006). FDG-PET for the routine follow-up in NHL: First prospective evaluation. Journal of Clinical Oncology, 24 (18, Part 1 Suppl. S), 439.

WILLEMS, E., CASTERMANS, E., Baron, F., BAUDOUX, E., Wanten, N., Bonnet, C., HAFRAOUI, K., Frère, P., Fillet, G., & Beguin, Y. (2006). Nonmyeloablative stem cell transplantation with CD8-depleted or unmalipulated peripheral blood stem cells: a prospective randomized trial [Paper presentation]. 21st General Meeting of the Belgian Hematological Society.

Bonnet, C., Fillet, G., Mounier, N., Ganem, G., Molina, T., Thieblemont, C., Ferme, C., Quesnel, B., Martin, C., Gisselbrecht, C., Tilly, H., & Reyes, F. (2006). No role for chemoradiotherapy compared with chemotherapy alone in elderly patients with localized low risk aggressive lymphoma: final results of the LNH93-4 GELA study [Poster presentation]. 21st General Meeting of the Belgian Hematological Society.

Pierard, C., Pierard, G., Quatresooz, P., Arrese Estrada, J., Rorive, A., & Fillet, G. (2006). Hic et Nunc. Naevus ou melanome? Revue Médicale de Liège, 61 (1), 43-7.

Jehn, U., Suciu, S., Thomas, X., Lefrère, F., Muus, P., Berneman, Z., Marie, J.-P., Adamo, F., Fillet, G., Nobile, F., Ricciuti, F., Leone, G., Rizzoli, V., Montanaro, M., Beeldens, F., Fazi, P., Mandelli, F., Willemze, R., de Witte, T., & Amadori, S. (2006). Non-infusional vs intravenous consolidation chemotherapy in eldery patients with acute myeloid leukemia : final results of th EORTC-GIMAMA AML-13 randomized phase III trial. Leukemia, 20, 1723-1730. doi:10.1038/sj.leu.2404356

Bonnet, C., Fillet, G., Mounier, N., Ganem, G., Molina, T., Thieblemont, C., Fermé, C., Quesnel, B., Martin, C., Gisselbrecht, C., Tilly, H., & Reyes, F. (January 2006). No role for chemoradiotherapy when compared with chemotherapy alone in elderly patients with localized low risk aggressie lymphoma: final results of the LNH 93-4 GELA Study [Poster presentation]. 21st General Meeting of the Belgian Hematological Society.

Jerusalem, G., Rorive, A., Ancion, G., Hustinx, R., & Fillet, G. (2006). Diagnostic and therapeutic management of carcinoma of unknown primary: radio-imaging investigations. Annals of Oncology, 17 Suppl 10, 168-76. doi:10.1093/annonc/mdl255

Bonnet, C., Beguin, Y., FASSOTTE, M.-F., & Fillet, G. (2006). Limited usefulness of CA 125 measurement in the management of hodgkin's and non-hodgkin's lymphomas [Poster presentation]. 21st General Meeting of the Belgian Hematological Society.

Vanstraelen, G., Baron, F., Willems, E., Bonnet, C., Hafraoui, K., Frere, P., Fillet, G., & Beguin, Y. (2006). Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response. Experimental Hematology, 34 (7), 841-50. doi:10.1016/j.exphem.2006.04.012

Frere, P., Baron, F., Bonnet, C., Hafraoui, K., Pereira-Martins, M., Willems, E., Fillet, G., & Beguin, Y. (2006). Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen. Bone Marrow Transplantation, 37 (4), 411-8. doi:10.1038/sj.bmt.1705255

Frere, P., Pereira-Martins, M., Fillet, G., & Beguin, Y. (2006). Infections after CD34-selected or unmanipulated autologous hematopoietic stem cell transplantation. European Journal of Haematology, 76 (2), 102-8. doi:10.1111/j.1600-0609.2005.00569.x

Vanstraelen, G., Frere, P., Ngirabacu, M.-C., Willems, E., Fillet, G., & Beguin, Y. (2006). Pegfilgrastim compared with Filgrastim after autologous hematopoietic peripheral blood stem cell transplantation. Experimental Hematology, 34 (3), 382-8. doi:10.1016/j.exphem.2005.11.013

Amadori, S., Suciu, S., Jehn, U., Stasi, R., Thomas, X., Marie, J.-P., Muus, P., Lefrère, F., Berneman, Z., Fillet, G., Denzlinger, C., Willemze, R., Leoni, P., Leone, G., Casini, M., Ricciuti, F., Vignetti, M., Beeldens, F., Mandelli, F., & de Witte, T. (2005). Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia : final results of AML-13, a randomized phase-3 study. Blood, 106, 27-34. doi:10.1182/blood-2004-09-3728

Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2005). Evaluation of therapy for lymphoma. Seminars in Nuclear Medicine, 35 (3), 186-96. doi:10.1053/j.semnuclmed.2005.02.004

Wauters, O., Sautois, B., & Fillet, G. (2005). L'image du mois. Une image de "lâcher de ballons" à l'imagerie thoracique. Revue Médicale de Liège, 60, 909.

Fillet, G., Bonnet, C., Mounier, N., Ganem, G., Molina, T., Thieblemont, C., Fermé, C., Quesnel, B., Martin, C., Gisselbrecht, C., Tilly, H., & Reyes, F. (2005). No role for chemoradiotherapy when compared with chemotherapy alone in elderly patients with localized low risk aggressive lymphoma: final results of the LNH93-4 GELA study. Blood, 106 (15).

Farcy, L., Fillet, G., Couvreur, V., & Triffaux, J.-M. (2005). L'anémie par spoliation sanguine volontaire : le syndrome de Lasthénie de Ferjol. Revue Médicale de Liège, 60 (9), 719-723.

Willems, E., Baron, F., Vanstraelen, G., Frere, P., Fillet, G., & Beguin, Y. (2005). Immunotherapie du cancer par minigreffe de cellules souches hematopoietiques. Revue Médicale Suisse, 1 (30), 1973-7.

Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2005). Whole-Body Positron Emission Tomography using 18F-Fluorodeoxyglucose for Staging Response Assessment in Hodgkin's Disease. In B. C. Heinz (Ed.), Trends in Hodgkin's Disease Research (pp. 169-188). New York, United States: Nova Science Publishers.

Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2005). Positron emission tomography imaging for lymphoma. Current Opinion in Oncology, 17 (5), 441-5. doi:10.1097/01.cco.0000174041.29557.5c

WILLEMS, E., CASTERMANS, E., Baron, F., BAUDOUX, E., Wanten, N., Bonnet, C., HAFRAOUI, K., Frère, P., Fillet, G., & Beguin, Y. (2005). Nonmyeloablative stem cell transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a prospective randomized trial. Blood, 106 (1075).

Fillet, G., Bonnet, C., Mounier, N., Ganem, N., Molina, T., Thieblemont, C., Fermé, C., Quesnel, B., Martin, C., Gisselbrecht, C., Tilly, H., & Reyes. (2005). No advantage of chemoradiotherapy over chemotherapy alone in elderly patients with localized low risk aggressive lymphoma: results of the LNH93-4 GELA study. Annals of Oncology, 16 (suppl 5).

Vanstraelen, G., Baron, F., Frere, P., Hafraoui, K., Fillet, G., & Beguin, Y. (2005). Efficacy of recombinant human erythropoietin therapy started one month after autologous peripheral blood stem cell transplantation. Haematologica, 90 (9), 1269-70.

Labar, B., Suciu, S., Zittoun, R., Muus, P., Marie, J.-P., Fillet, G., Peetermans, M., Stryckmans, P., Willemze, R., Feremans, W., Jaksic, B., Bourhis, J.-H., Burghouts, J.-P., & De Witte, T. (July 2004). Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients <= 50 years old in first complete remission: results of the EORTC ALL-3 trial. Haematologica, 89 (7), 809-817.

Polus, M., Piront, P., Jerusalem, G., Sautois, B., Defechereux, T., de Leval, L., & Fillet, G. (February 2004). L'image du mois. Tumeur de Merkel : reponse majeure a la chimiotherapie. "Il n'y a pas que la neige qui fond au soleil". Revue Médicale de Liège, 59 (2), 67-8.

Gillain, S., Gennigens, C., Sautois, B., Polus, M., Bonnet, C., Fillet, G., & Jerusalem, G. (2004). Traitement du cancer du sein chez la personne âgée. Revue Médicale Suisse, 62, 1618-21.

Frere, P., Hermanne, J.-P., Debouge, M.-H., De Mol, P., Fillet, G., & Beguin, Y. (2004). Bacteremia after hematopoietic stem cell transplantation: incidence and predictive value of surveillance cultures. Bone Marrow Transplantation, 33 (7), 745-9. doi:10.1038/sj.bmt.1704414

Baron, F., Copizza, S., Baudoux, E., Jerusalem, G., Fillet, G., & Beguin, Y. (2004). CD34+ cell dose predicts costs after autologous peripheral blood stem cell transplantation for breast cancer. Haematologica, 89 (9), 1146-8.

Pirson, L., Baron, F., Giet, O., Meuris, N., Bours, V., Fillet, G., Gothot, A., & Beguin, Y. (2004). The tyrosine kinase inhibitor Imatinib increases irradiation toxicity but does not impair engraftment of human CD34+ cells into NOD/SCIDB2mNull mice [Poster presentation]. 19th general meeting of the Belgian Hematological Society, Brussels, Belgium.

Polus, M., Piront, P., Jerusalem, G., Sautois, B., Louis, E., Detroz, B., Laurent, S., Belaiche, J., & Fillet, G. (April 2003). Prevention primaire et secondaire du cancer colorectal. Revue Médicale de Liège, 58 (4), 247-53.

Tilly, H., Lepage, E., Coiffier, B., Blanc, M., Herbrecht, R., Bosly, A., Attal, M., Fillet, G., Guettier, C., Jo Molina, T., Gisselbrecht, C., & Reyes, F. (2003). Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma. Blood, 102 (13), 4284-4289. doi:10.1182/blood-2003-02-0542

Baron, F., Frere, P., Fillet, G., & Beguin, Y. (2003). Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment. Clinical Cancer Research, 9 (15), 5566-72.

Jerusalem, G., Beguin, Y., Fassotte, M.-F., Belhocine, T., Hustinx, R., Rigo, P., & Fillet, G. (2003). Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease. Annals of Oncology, 14 (1), 123-30. doi:10.1093/annonc/mdg011

Jerusalem, G., Hustinx, R., Beguin, Y., Depas, G., Fassotte, M.-F., De Barsy, C., Foidart, J., & Fillet, G. (2003). Les lymphomes. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 27 (8), 401-410.

Andre, M., Baudoux, E., Bron, D., Canon, J.-L., D'Hondt, V., Fassotte, M.-F., D'Hondt, L., Fillet, G., Humblet, Y., Jerusalem, G., Vermeulen, P., Symann, M., & Beguin, Y. (2003). Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies. Transfusion, 43 (1), 50-7. doi:10.1046/j.1537-2995.2003.00273.x

Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2003). PET scan imaging in oncology. European Journal of Cancer, 39 (11), 1525-34. doi:10.1016/S0959-8049(03)00374-5

Baron, F., Frere, P., Baudoux, E., Sautois, B., Fillet, G., & Beguin, Y. (2003). Non-myeloablative stem cell transplantation with low-dose total body irradiation and fludarabine for metastatic renal cell carcinoma. Haematologica, 88 (4), 478-80.

Bonnet, C., Fillet, G., Bosly, A., Van Hoof, A., Offner, F., Van Den Neste, E., DE PRIJCK, B., Deflandre, A., Gisselbrecht, C., & Reyes, F. (2003). Radiotherapy is unnecessary in elderly patients with localized aggressive non hodgkin's lymphoma: results of the LNH 93-4 study [Paper presentation]. 18th General Meeting of the Belgian Hematological Society, Brussels, Belgium.

Pirson, L., Baron, F., Giet, O., Meuris, N., Bours, V., Fillet, G., Gothot, A., & Beguin, Y. (2003). Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor STI571 does not impair engraftment of human CD34+ cells into NOD/SCIDB2mNull mice [Poster presentation]. 32nd annual meeting of the International Society of Experimental Hematology, Paris, France.

Pirson, L., Baron, F., Giet, O., Meuris, N., Bours, V., Fillet, G., Gothot, A., & Beguin, Y. (2003). Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor STI571 does not impair engraftment of human CD34+ cells into NOD/SCIDB2mNull mice [Poster presentation]. 18th general meeting of the Belgian Hematological Society, Brussels, Belgium.

Hafraoui, K., Humblet-Baron, S., Baron, F., Beguin, Y., & Fillet, G. (2003). Comment je traite ... la leucemie myeloide chronique (LMC). Revue Médicale de Liège, 58 (1), 7-12.

Baron, F., Baudoux, E., Frere, P., Tourqui, S., Schaaf-Lafontaine, N., Herens, C., De Prijck, B., Fillet, G., & Beguin, Y. (2003). Low T-cell chimerism is not followed by graft rejection after nonmyeloablative stem cell transplantation (NMSCT) with CD34-selected PBSC. Bone Marrow Transplantation, 32 (8), 829-34. doi:10.1038/sj.bmt.1704220

Baron, F., Frere, P., Fillet, G., & Beguin, Y. (2003). Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin therapy given between first and second HDT allows second peripheral blood stem cell transplantation without red blood cell transfusion. British Journal of Haematology, 123 (1), 103-5. doi:10.1046/j.1365-2141.2003.04556.x

Baron, F., Schaaf-Lafontaine, N., Humblet-Baron, S., Meuris, N., Castermans, E., Baudoux, E., Frere, P., Bours, V., Fillet, G., & Beguin, Y. (2003). T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation. Transplantation, 76 (12), 1705-13. doi:10.1097/01.TP.0000093987.11389.F7

Keating, S., Suciu, S., de Witte, T., Zittoun, R., Mandelli, F., Belhabri, A., Amadori, S., Fibbe, W., Gallo, E., Fillet, G., Varet, B., Meloni, G., Hagemeijer, A., Fazi, P., Solbu, G., & Willemze, R. (January 2003). The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial. Leukemia, 17 (1), 60-67. doi:10.1038/sj.leu.2402782

Baron, F., Frere, P., Baudoux, E., Schaaf-Lafontaine, N., Fillet, G., & Beguin, Y. (2003). Low incidence of acute graft-versus-host disease after non-myeloablative stem cell transplantation with CD8-depleted peripheral blood stem cells: an update. Haematologica, 88 (7), 835-7.

Pelerin, D., Silvestre, R. M., Jerusalem, G., Sautois, B., Polus, M., & Fillet, G. (December 2002). Comment je traite ... par hormonotherapie des patientes developpant des complications thrombo-emboliques lors du traitement d'un cancer du sein par tamoxifene. Revue Médicale de Liège, 57 (12), 755-6.

Polus, M., Honore, P., De Roover, A., Detry, O., Detroz, B., Jerusalem, G., Sautois, B., & Fillet, G. (December 2002). La carcinomatose hepatique du cancer colorectal: actualites therapeutiques. Revue Médicale de Liège, 57 (12), 771-8.

Humblet-Baron, S., Baron, F., Pirson, L., Beguin, Y., & Fillet, G. (28 August 2002). Traitement moléculaire du cancer: le STI571, un inhibiteur des tyrosines kinases. Revue Médicale Suisse, 60 (598), 1504-1508.

Polus, M., Bours, V., Jerusalem, G., Sautois, B., & Fillet, G. (July 2002). Comment je traite.... Le cancer avance du pancreas par une approche innovante dirigee contre les nouvelles cibles. Revue Médicale de Liège, 57 (7), 428-32.

Gisselbrecht, C., Lepage, E., Molina, T., Quesnel, B., Fillet, G., Lederlin, P., Coiffier, B., Tilly, H., Gabarre, J., Guilmin, F., Hermine, O., & Reyes, F. (15 May 2002). Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma. Journal of Clinical Oncology, 20 (10), 2472-2479. doi:10.1200/JCO.2002.02.125

Polus, M., Jerusalem, G., Sautois, B., Silvestre, R. M., & Fillet, G. (March 2002). Comment je traite.... Un cancer du pancreas avance. Revue Médicale de Liège, 57 (3), 131-4.

Polus, M., Jerusalem, G., Sautois, B., Silvestre, R. M., Collette, M. Y., Closon, M. T., & Fillet, G. (February 2002). Etude clinique du mois. Radio-chimiotherapie et chimiotherapie adjuvante apres resection a visee curative du cancer du pancreas: resultats de l'etude randomisee ESPAC-1. Revue Médicale de Liège, 57 (2), 119-22.

Baron, F., Frere, P., Herens, C., Fillet, G., & Beguin, Y. (2002). Combination of nonmyeloablative stem cell transplantation and Imatinib in accelerated phase CML. Haematologica, 87 (12), 43.

Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2002). The value of positron emission tomography (PET) imaging in disease staging and therapy assessment. Annals of Oncology, 13 Suppl 4, 227-34. doi:10.1093/annonc/mdf664

Frere, P., Hermanne, J.-P., Debouge, M.-H., Fillet, G., & Beguin, Y. (2002). Changing pattern of bacterial susceptibility to antibiotics in hematopoietic stem cell transplant recipients. Bone Marrow Transplantation, 29 (7), 589-94. doi:10.1038/sj/bmt/1703413

Pirson, L., Baron, F., Giet, O., Meuris, N., Bours, V., Fillet, G., Gothot, A., & Beguin, Y. (2002). Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibior STI571 does not impair engraftment of human CD34+ cells into NOD/SCIDB2mNull mice [Poster presentation]. 44th annual meeting and exposition of American Society of Hematology, Philadelphia, United States.

Warland, V., Jerusalem, G., Hustinx, R., Beguin, Y., Silvestre, R. M., Fassotte, M.-F., Foidart, J., & Fillet, G. (2002). Comment etablir le bilan de fin de traitement des patients atteints de lymphomes non-hodgkiniens (LNH) de malignite intermediaire ou elevee? Revue Médicale de Liège, 57 (12), 779-84.

Baron, F., Sautois, B., Baudoux, E., Matus, G., Fillet, G., & Beguin, Y. (2002). Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation. Experimental Hematology, 30 (6), 546-54. doi:10.1016/S0301-472X(02)00795-6

Bonnet, C., Fillet, G., Mounier, N., Thieblemont, C., Fermé, C., Quesnel, B., Martin, C., Blanc, M., Conroy, T., Penny, A., Petrella, T., & Reyes, F. (2002). Radiotherapy is unnecessary in elderly patients with localized agressive non Hodgkin's lymphoma: results of the LNH 93-4 study. Annals of Oncology, 13 (suppl 2), 27.

Bonnet, C., Fillet, G., Mounier, N., Thieblemont, C., Fermé, C., Quesnel, B., Martin, C., Blanc, M., Conroy, T., Penny, A. M., Petrella, T., & Reyes, F. (2002). Radiotherapy is unnecessary in elderly patients with localized agressive non Hodgkin's lymphoma: results of the LNH 93-4 study. Blood, 100 (11), 92.

Baron, F., Baudoux, E., Frere, P., Tourqui, S., Schaaf-Lafontaine, N., Greimers, R., Herens, C., Fillet, G., & Beguin, Y. (2002). Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cells. Journal of Hematotherapy and Stem Cell Research, 11 (2), 301-14. doi:10.1089/152581602753658484

Baron, F., Siquet, J., Schaaf-Lafontaine, N., Baudoux, E., Hermanne, J.-P., Fillet, G., & Beguin, Y. (2002). Pre-emptive immunotherapy with CD8-depleted donor lymphocytes after CD34-selected allogeneic peripheral blood stem cell transplantation. Haematologica, 87 (1), 78-88.

Baron, F., Baudoux, E., Fillet, G., & Beguin, Y. (2002). Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantation. Hematology, 7 (3), 137-43. doi:10.1080/1024533021000008173

Brasseur, E., Silvestre, R.-M., Jerusalem, G., Sautois, B., Polus, M., & Fillet, G. (2002). Prévention et traitement des nausées et vomissements après chimiothérapie anticancéreuse. Médecine et Hygiène, 60, 1509-1513.

Baron, F., Fillet, G., & Beguin, Y. (2002). Erythropoiesis after nonmyeloablative stem-cell transplantation is not impaired by inadequate erythropoietin production as observed after conventional allogeneic transplantation. Transplantation, 74 (12), 1692-6. doi:10.1097/00007890-200212270-00008

Najjar, F., Hustinx, R., Jerusalem, G., Fillet, G., & Rigo, P. (August 2001). Positron Emission Tomography (PET) for Staging Low-Grade Non-Hodgkin's Lymphomas (NHL). Cancer Biotherapy and Radiopharmaceuticals, 16 (4), 297-304. doi:10.1089/108497801753131372

Sylvestre, R.-M., Jerusalem, G., Sautois, B., Beguin, Y., & Fillet, G. (2001). Nouvelles approches thérapeutiques puor l'hypernéphrome métastasique. Médecine et Hygiène, 59, 1607-1609.

Sautois, B., Baudoux, E., Salmon, J., Michaux, S., Schaaf-Lafontaine, N., Pereira-Martins, M., Paulus, J.-M., Fillet, G., & Beguin, Y. (2001). Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation. Haematologica, 86 (11), 1209-18.

Jerusalem, G., Beguin, Y., Najjar, F., Hustinx, R., Fassotte, M.-F., Rigo, P., & Fillet, G. (2001). Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Annals of Oncology, 12 (6), 825-30. doi:10.1023/A:1011169332265

Langouet, A.-M., Brice, P., Simon, D., Bocaccio, C., Munck, J. N., Fillet, G., Peny, A.-M., Salles, G., Quesnel, B., Lefrere, F., Reyes, F., & Gisselbrecht, C. (2001). Factors affecting hematopoietic recovery after autologous peripheral blood progenitof-cell transplantation in aggressive non-Hodgkin's lymphoma : a prospective study of 123 patients. Hematology Journal, 2, 81-86. doi:10.1038/sj.thj.6200081

Piron, M., Loo, M., Gothot, A., Tassin, F., Fillet, G., & Beguin, Y. (2001). Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia. Blood, 97 (2), 442-8. doi:10.1182/blood.V97.2.442

Bosly, A., Lepage, E., Coiffier, B., Fillet, G., Herbrecht, R., Divine, M., Dupriez, B., Nouvel, C., Deconninck, E., Tilly, H., Bordessoule, D., Gaulard, P., & Gisselbrecht, C. (2001). Outcome is not improved by the use of alternating chemotherapy in elderly patients with aggressive lymphoma. Hematology Journal, 2, 279-285. doi:10.1038/sj.thj.6200116

Baron, F., Frere, P., Fillet, G., & Beguin, Y. (2001). Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571. Haematologica, 86 (9), 993-4.

Jerusalem, G., Belhocine, T., Silvestre, R.-M., Sautois, B., Hustinx, R., Beguin, Y., Fillet, G., & Rigo, P. (2001). Place de la tomographie d'émission de positons dans le suivi thérapeutique du cancer du sein. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 25 (6), 341-346.

Boogaerts, M., Maertens, J., van Hoof, A., de Bock, R., Fillet, G., Peetermans, M., Selleslag, D., Vandercam, B., Vandewoude, K., Zachée, P., & De Beule, K. (2001). Intraconzole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients. Journal of Antimicrobial Chemotherapy, 48, 97-103. doi:10.1093/jac/48.1.97

Jerusalem, G., Beguin, Y., Fassotte, M.-F., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (2001). Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease. Haematologica, 86 (3), 266-73.

Fillet, G., & Beguin, Y. (2001). Monitoring of erythropoiesis by the serum transferrin receptor and erythropoietin. Acta Clinica Belgica, 56 (3), 146-54. doi:10.1179/acb.2001.024

Scerbo, F., Matus, G., Sautois, B., & Fillet, G. (November 2000). Comment je traite ... le myelome multiple refractaire par thalidomide. Revue Médicale de Liège, 55 (11), 970-3.

Lechanteur, C., Delvenne, P., Princen, F., Lopez Y Cadenas, M., Fillet, G., Gielen, J., Merville, M.-P., & Bours, V. (September 2000). Combined Suicide and Cytokine Gene Therapy for Peritoneal Carcinomatosis. Gut, 47 (3), 343-8. doi:10.1136/gut.47.3.343

Jerusalem, G., Bours, V., & Fillet, G. (May 2000). Traitement adjuvant du cancer du sein: meta-analyse et recommandations therapeutiques. Revue Médicale de Liège, 55 (5), 356-9.

Jerusalem, G., Bours, V., & Fillet, G. (March 2000). Existe-t-il des progres dans le traitement du cancer du pancreas metastatique? Revue Médicale de Liège, 55 (3), 146-8.

Bonnet, C., Jerusalem, G., Bours, V., & Fillet, G. (2000). Approches thérapeutiques du cancer ovarien. Médecine et Hygiène, 58, 1625-1628.

Fraipont, V., Sautois, B., Baudoux, E., Pereira-Martins, M., Fassotte, M.-F., Hermanne, J. P., Jerusalem, G., Longree, L., Schaaf-Lafontaine, N., Fillet, G., & Beguin, Y. (2000). Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+ cells and/or CFU-GM with chemotherapy and G-CSF. Transfusion, 40 (3), 339-47. doi:10.1046/j.1537-2995.2000.40030339.x

Frere, P., Canivet, J.-L., Gennigens, C., Rebeix, J. P., Fillet, G., & Beguin, Y. (2000). Hyperammonemia after high-dose chemotherapy and stem cell transplantation. Bone Marrow Transplantation, 26 (3), 343-5. doi:10.1038/sj.bmt.1702485

Jerusalem, G., Beguin, Y., Fassotte, M.-F., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (2000). Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma. Haematologica, 85 (6), 613-8.

Jerusalem, G., Beguin, Y., Fassotte, M.-F., Belhocine, T., Najjar, F., Hustinx, R., Rigo, P., & Fillet, G. (2000). Evaluation thérapeutique précoce par tomographie à émission de positons. Médecine et Hygiène, 58, 1629-1632.

Baron, F., Gothot, A., Salmon, J., Hermanne, J. P., Pierard, G., Fillet, G., & Beguin, Y. (2000). Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation. British Journal of Haematology, 111 (3), 745-53. doi:10.1046/j.1365-2141.2000.02470.x

JERUSALEM, G., BEGUIN, Y., FASSOTTE, M.-F., BELHOCINE, T., HUSTINX, R., RIGO, P., & FILLET, G. (2000). Early detection of relapse by whole-body positron emission tomography (PET) using 18F-fluorodeoxyglucose (18F-FDG) in the follow-up of patients with Hodgkin’s disease (HD). PROCEEDINGS OF AMERICAN SOCIETY OF CLINICAL ONCOLOGY ANNUAL MEETING 2000, 19, 10.

NAJJAR, F., HUSTINX, R., JERUSALEM, G., FILLET, G., & RIGO, P. (2000). Whole-body 18FDG-PET for staging low grade non Hodgkin’s lymphoma. European Journal of Nuclear Medicine, 27, 1159.

Bentires-Alj, M., Hellin, A.-C., Lechanteur, C., Princen, F., Lopez Y Cadenas, M., Fillet, G., Gielen, J.-L., Merville, M.-P., & Bours, V. (January 2000). Cytosine Deaminase Suicide Gene Therapy for Peritoneal Carcinomatosis. Cancer Gene Therapy, 7 (1), 20-6. doi:10.1038/sj.cgt.7700093

Sautois, B., Scerbo, F., Beguin, Y., & Fillet, G. (2000). Traitement des myélomes réfractaires par la Thalidomide. Médecine et Hygiène, 58, 1633-1634.

Mattson, K., Vansteenkiste, J., Stupp, R., Bargetzi, M., Saarinen, A., Jekunen, A., Fillet, G., Teixeira, M., Gatzemeier, U., Olivares, R., Soussan-Lazard, K., & Berille, J. (2000). Phase II study of docetaxel alternating with cisplatin in chemotherapy-naïve patients with advanced non-small cell lung cancer. Anti-Cancer Drugs, 11, 7-13. doi:10.1097/00001813-200001000-00002

Baron, F., Ribbens, C., Kaye, O., Fillet, G., Malaise, M., & Beguin, Y. (2000). Effective treatment of Jo-1-associated polymyositis with T-cell-depleted autologous peripheral blood stem cell transplantation. British Journal of Haematology, 110 (2), 339-342. doi:10.1046/j.1365-2141.2000.02191.x

Rorive, A., Fraipont, V., Quatresooz, P., Cataldo, D., Dubois, B., & Fillet, G. (March 1999). A propos d'un cas de rhabdomyolyse aigue. Revue Médicale de Liège, 54 (3), 143-8.

Archimbaud, E., Jehn, U., Thomas, X., De Cataldo, F., Fillet, G., Belhabri, A., Peaud, P.-Y., Martin, C., Amadori, S., & Willemze, R. (1999). Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction/consolidation therapy, followed by a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia. Leukemia, 13, 843-849. doi:10.1038/sj.leu.2401445

Van Cutsem, E., Cunningham, D., Ten Bokkel Huinink, W. W., Punt, C. J. A., Alexopoulos, C. G., Dirix, L., Symann, M., Blijham, G. H., Cholet, P., Fillet, G., Van Groeningen, C., Vannetzel, J. M., Levi, F., Panagos, G., Unger, C., Wils, J., Cote, C., Blanc, C., Hérait, P., & Bleiberg, H. (1999). Clinical Activity and Benefit of Irinotecan (CPT-11) in Patients with Colorectal Cancer Truly Resistant to 5-Fluorouracil (5-FU). European Journal of Cancer, 35, 54-59. doi:10.1016/S0959-8049(98)00353-0

Sautois, B., Fraipont, V., Baudoux, E., Fassotte, M.-F., Hermanne, J. P., Jerusalem, G., Bours, V., Bosquee, L., Schaaf-Lafontaine, N., Paulus, J.-M., Sondag, D., Fillet, G., & Beguin, Y. (1999). Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields. Haematologica, 84 (4), 342-9.

Najjar, F., Jerusalem, G., Paulus, P., Fillet, G., & Rigo, P. (1999). Intérêt clinique de la tomographie à émission de positons dans la détection et le bilan d'extension des lymphomes non Hodgkiniens de malignité intermédiaire ou élevée. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 23, 281-290.

Rezaei Kalantari, H., Jerusalem, G., Bours, V., & Fillet, G. (January 1999). Les tumeurs malignes d'origine indéterminée. Revue Médicale de Liège, 54 (1), 39-42.

Jerusalem, G., Beguin, Y., Fassotte, M.-F., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (1999). Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood, 94 (2), 429-33. doi:10.1182/blood.v94.2.429.414k26_429_433

Herens, C., Hermanne, J.-P., Tassin, F., Fassotte, M.-F., Thiry, A., Jamar, M., Schaaf-Lafontaine, N., Fillet, G., & Koulischer, L. (1999). Translocation (2;3)(p21;q26) as the sole anomaly in a case of primary myelofibrosis. Cancer Genetics and Cytogenetics, 110 (1), 62-4. doi:10.1016/S0165-4608(98)00186-1

Jerusalem, G., Bours, V., & Fillet, G. (1999). Actualités thérapeutiques dans le traitement du cancer colorectal. Médecine et Hygiène, 57, 1552-1554.

Salmon, J., Michaux, S., Hermanne, J. P., Baudoux, E., Gerard, C., Sondag, D., Fillet, G., & Beguin, Y. (1999). Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation. Transfusion, 39 (8), 824-7. doi:10.1046/j.1537-2995.1999.39080824.x

Jerusalem, G., Warland, V., Najjar, F., Paulus, P., Fassotte, M. F., Fillet, G., & Rigo, P. (January 1999). Whole-Body 18f-Fdg Pet for the Evaluation of Patients with Hodgkin's Disease and Non-Hodgkin's Lymphoma. Nuclear Medicine Communications, 20 (1), 13-20. doi:10.1097/00006231-199901000-00004

Princen, F., Lechanteur, C., Lopez Y Cadenas, M., Rocoux, G., Detroz, B., Gielen, J.-L., Fillet, G., Merville, M.-P., & Bours, V. (August 1998). Repeated Cycles of Retrovirus-Mediated Hsvtk Gene Transfer Plus Ganciclovir Increase Survival of Rats with Peritoneal Carcinomatosis. Gene Therapy, 5 (8), 1054-60. doi:10.1038/sj.gt.3300710

Tassin, F., Hermanne, J.-P., Schaaf-Lafontaine, N., Herens, C., Thiry, A., Paulus, J.-M., Boniver, J., & Fillet, G. (June 1998). Les syndromes myélodysplasiques: syndromes préleucémiques. Revue Médicale de Liège, 53 (6), 357-62.

Jerusalem, G., Bours, V., & Fillet, G. (June 1998). Pharma-clinics. Comment je traite... II. Approche thérapeutique du cancer colorectal métastatique. Revue Médicale de Liège, 53 (6), 318-21.

Jerusalem, G., Bours, V., & Fillet, G. (May 1998). Traitement du cancer colorectal. Aspects pharmaco-économiques. Revue Médicale de Liège, 53 (5), 276-8.

Bours, V., Jerusalem, G., & Fillet, G. (April 1998). Comment je traite ... Le cancer colorectal: I. Prévention et traitement adjuvant. Revue Médicale de Liège, 53 (4), 167-70.

Baudoux, E., Beguin, Y., Cornu, G., Brichard, B., Debruyn, C., De Bruyere, M., De Hemptinne, D., Delforge, A., Deneys, V., Fillet, G., Germeau, N., Joris, I., Lefevre, P., Massy, M., Paulus, J.-M., Raymakers, N., Schaaps, J.-P., Sondag, D., Van Cauwenberge, J.-R., ... Strijckmans, P. (1998). Circadian and seasonal variations of hematopoiesis in cord blood. Bone Marrow Transplantation, 22 Suppl 1, 12.

Baron, F., Hermanne, J.-P., Dowlati, A., Weber, T., Thiry, A., Fassotte, M.-F., Fillet, G., & Beguin, Y. (1998). Bronchiolitis obliterans organizing pneumonia and ulcerative colitis after allogeneic bone marrow transplantation. Bone Marrow Transplantation, 21 (9), 951-4. doi:10.1038/sj.bmt.1701198

Lechanteur, C., Princen, F., Lo Bue, S., Detroz, B., Fillet, G., Gielen, J., Bours, V., & Merville, M.-P. (1998). Hsv-1 Thymidine Kinase Gene Therapy for Peritoneal Carcinomatosis. Advances in Experimental Medicine and Biology, 451, 115-9. doi:10.1007/978-1-4615-5357-1_18

Baron, F., Hermanne, J. P., Fassotte, M.-F., Beguin, Y., & Fillet, G. (1998). Le cas clinique du mois. Association d'une maladie de Hodgkin et d'un syndrome nephrotique. Revue Médicale de Liège, 53 (11), 651-3.

Löwenberg, B., Suciu, S., Archimbaud, E., Haak, H., Stryckmans, P., De Cataldo, R., Dekker, A. W., Berneman, Z. N., Thyss, A., van der Lelie, J., Sonneveld, P., Visani, G., Fillet, G., Hayat, M., Hagemeijer, A., Solbu, G., & Zittoun, R. (1998). Mitoxantrone Versus Daunorubicin in Induction-Consolidation Chemotherapy - The Value of Low-Dose Cytarabine for Maintenance of Remission, and an Assessment of Prognostic Factors in Acute Myeloid Leukemia in the Elderly : Final Report of the Leukemia Cooperative Group of the European Organization for the Research and Treatment of Cancer and th Dutch-Belgian Hemato-Oncology Cooperative Hovon Group Randomized Phase III Study AML-9. Journal of Clinical Oncology, 16, 872-881. doi:10.1200/JCO.1998.16.3.872

Pierard, G., Nikkels, N., Nikkels, A., Arrese Estrada, J., Pierard, C., Jerusalem, G., Beguin, Y., & Fillet, G. (1998). Epidermal Calprotectin Expression in Lymphocyte-Depleted Cutaneous Graft-versus-Host Reaction. Archivos Argentinos de Dermatologia, 48, 139-142.

Beguin, Y., Baudoux, E., Sautois, B., Fraipont, V., Schaaf-Lafontaine, N., Pereira-Martins, M., Paulus, J.-M., Sondag, D., & Fillet, G. (1998). Hematopoietic recovery in cancer patients after transplantation of autologous peripheral blood CD34+ cells or unmanipulated peripheral blood stem and progenitor cells. Transfusion, 38 (2), 199-208. doi:10.1046/j.1537-2995.1998.38298193106.x

Beguin, Y., Baron, F., & Fillet, G. (1998). Influence of marrow erythropoietic activity on serum erythropoietin levels after autologous hematopoietic stem cell transplantation. Haematologica, 83 (12), 1076-81.

Lechanteur, C., Princen, F., Lo Bue, S., Detroz, B., Fillet, G., Gielen, J.-L., Bours, V., & Merville, M.-P. (November 1997). Hsv-1 Thymidine Kinase Gene Therapy for Colorectal Adenocarcinoma-Derived Peritoneal Carcinomatosis. Gene Therapy, 4 (11), 1189-94. doi:10.1038/sj.gt.3300520

Jerusalem, G., & Fillet, G. (April 1997). Problèmes diagnostiques, thérapeutiques et socio-économiques en oncologie gériatrique. Revue Médicale de Liège, 52 (4), 255-7.

Jerusalem, G., & Fillet, G. (1997). Les taxanes : un nouvelle classe d'agents cytotoxiques. Médecine et Hygiène, 55, 1501-1504.

Dowlati, A., Loo, Bury, T., Fillet, G., & Beguin, Y. (1997). Soluble and cell-associated transferrin receptor in lung cancer. British Journal of Cancer, 75 (12), 1802-6. doi:10.1038/bjc.1997.307

Sautois, B., Fillet, G., & Beguin, Y. (1997). Comparative cytokine production by in vitro stimulated mononucleated cells from cord blood and adult blood. Experimental Hematology, 25 (2), 103-8.

Beguin, Y., Sautois, B., Forget, P., Bury, J., & Fillet, G. (1997). Long term follow-up of patients with acute myelogenous leukemia who received the daunorubicin, vincristine, and cytosine arabinoside regimen. Cancer, 79 (7), 1351-4. doi:10.1002/(SICI)1097-0142(19970401)79:7<1351::AID-CNCR12>3.0.CO;2-Z

Beguin, Y., Grek, V., Weber, G., Sautois, B., Paquot, N., Pereira-Martins, M., Scheen, A., Lefèbvre, P., & Fillet, G. (1997). Acute Functional Iron Deficiency in Obese Subjects During a Very-Low-Energy All-Protein Diet. American Journal of Clinical Nutrition, 66 (1), 75-9. doi:10.1093/ajcn/66.1.75

Dowlati, A., R'Zik, S., Fillet, G., & Beguin, Y. (1997). Anaemia of lung cancer is due to impaired erythroid marrow response to erythropoietin stimulation as well as relative inadequacy of erythropoietin production. British Journal of Haematology, 97 (2), 297-9. doi:10.1046/j.1365-2141.1997.472694.x

Hermanne, J.-P., Tassin, F., Bours, V., & Fillet, G. (March 1996). Rétinoïdes et leucémie aigue promyelocytaire. Une révolution thérapeutique. Revue Médicale de Liège, 51 (3), 217-23.

Fillet, G. (January 1996). Les facteurs de croissance hematopoiétiques. Revue Médicale de Liège, 51 (1), 102-6.

Archimbaud, E., Jehn, U., De Cataldo, F., Fillet, G., Amadori, S., & Willemze, R. (1996). Autologous stem cell transplantations in elderly AML patients. Trends in Onco-Hematology, 4 (2), 28-29.

Beguin, Y., Lampertz, S., Bron, D., & Fillet, G. (1996). Serum erythropoietin in chronic lymphocytic leukaemia. British Journal of Haematology, 93 (1), 154-6. doi:10.1046/j.1365-2141.1996.452992.x

Hermanne, J.-P., TASSIN, F., Beguin, Y., & Fillet, G. (1996). Actualités thérapeutiques dans la thrombocytémie essentielle. Médecine et Hygiène, 54, 1487-1489.

Hermine, O., Haioun, C., Lepage, E., D'Agay, M.-F., Briere, J., Lavignac, C., Fillet, G., Salles, G., Marolleau, J.-P., Diebold, J., Reyes, F., & Gaulard, P. (1996). Prognostic Significance of bcl-2 Protein Expression in Aggressive Non-Hodkin's Lymphoma. Blood. doi:10.1182/blood.v87.1.265.bloodjournal871265

Hermanne, J.-P., TASSIN, F., Bours, V., & Fillet, G. (1996). Intérêt de l'acide rétinoïque "tous trans" dans le traitement de la leucémie aiguë promyélocytaire. Médecine et Hygiène, 54, 1472-1479.

Fillet, G. (1996). Maladie de Hodgkin et facteurs de croissance. Tempo Médical, 166, 75-77.

Beguin, Y., Collignon, J., Laurent, C., & Fillet, G. (1996). Spontaneous complete remission and recovery of donor haemopoiesis without GVHD after relapse and apparent marrow graft rejection in poor-prognosis myelodysplastic syndrome. British Journal of Haematology, 94 (3), 507-9. doi:10.1046/j.1365-2141.1996.d01-1824.x

Beguin, Y., Loo, M., R'Zik, S., Sautois, B., Lejeune, F., Rorive, G., & Fillet, G. (1995). Quantitative assessment of erythropoiesis in haemodialysis patients demonstrates gradual expansion of erythroblasts during constant treatment with recombinant human erythropoietin. British Journal of Haematology, 89 (1), 17-23. doi:10.1111/j.1365-2141.1995.tb08916.x

Jerusalem, G., Detroz, B., Herman, P., Dohogne, A., Closon, M. T., Jacquet, N., Honoré, P., Bruyninx, L., Fillet, G., Fassotte, M.-F., Bours, V., & Lipcsei, G. (1995). Approche thérapeutique du cancer épithélial de l'ovaire au CHU Sart Tilman : Conclusions de la réunion interdisciplinaire du 22 mars 1995. Revue Médicale de Liège, 50, 469-471.

Dowlati, A., Honore, P., Damas, P., Deprez, M., Delwaide, J., Fillet, G., & Beguin, Y. (1995). Hepatic rejection after orthotopic liver transplantation for hepatic veno-occlusive disease or graft-versus-host disease following bone marrow transplantation. Transplantation, 60 (1), 106-9. doi:10.1097/00007890-199507150-00020

Fraipont, V., Beguin, Y., & Fillet, G. (1994). L'anemie ferriprive de la grossesse. Revue Médicale de Liège, 49 (8), 436-45.

Beguin, Y., Loo, M., R'Zik, S., Sautois, B., & Fillet, G. (1994). Significance of soluble transferrin receptor. Molecular Biology of Hematopoiesis, 451-464.

Beguin, Y., Loo, M., R'Zik, S., Sautois, B., Lejeune, F., Rorive, G., & Fillet, G. (1994). Effect of recombinant human erythropoietin on platelets in patients with anemia of renal failure: correlation of platelet count with erythropoietic activity and iron parameters. European Journal of Haematology, 53 (5), 265-70. doi:10.1111/j.1600-0609.1994.tb01318.x

Delhougne, B., & Fillet, G. (February 1993). Aspects immunologiques et hématologiques de l'infection par le virus HIV. Revue Médicale de Liège, 48 (2), 72-80.

Beguin, Y., Oris, R., & Fillet, G. (1993). Dynamics of erythropoietic recovery following bone marrow transplantation: role of marrow proliferative capacity and erythropoietin production in autologous versus allogeneic transplants. Bone Marrow Transplantation, 11 (4), 285-92.

Baudoux, E., Janssens, M., Beguin, Y., Sondag, D., Fillet, G., & Lamy, M. (1993). Erythropoietin in surgery. In Proceedings of the 4th Regional Congress of the International Society of Blood Transfusion (pp. 213-217).

Beguin, Y., Clemons, G. K., Pootrakul, P., & Fillet, G. (1993). Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood, 81 (4), 1067-76. doi:10.1182/blood.v81.4.1067.1067

Nikkels, A., Hansen, I., Collignon, J., Fassotte, M. F., Fillet, G., & Pierard, G. (1993). Neutrophilic Eccrine Hidradenitis. A Case Report. Acta Clinica Belgica, 48 (6), 397-400. doi:10.1080/17843286.1993.11718336

Gautier, M. S., Pierard, G., Andrien, F., Hermanns, J.-F., Pierard-Franchimont, C., Fillet, G., & Lapiere, C. M. (1993). High-Grade Pleomorphic T Cell Lymphoma with Restricted Involvement of Skin and Bone Marrow. Dermatology, 186 (4), 287-9. doi:10.1159/000247378

Beguin, Y., Loo, M., R'Zik, S., Sautois, B., Lejeune, F., Rorive, G., & Fillet, G. (1993). Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrin receptor and fibrinogen. Blood, 82 (7), 2010-6. doi:10.1182/blood.v82.7.2010.bloodjournal8272010

Beguin, Y., Lampertz, S., De Groote, D., Igot, D., Malaise, M., & Fillet, G. (1993). Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia. Leukemia, 7 (12), 2019-2025.

Fillet, G., & Beguin, Y. (1992). Iron availability for erythropoiesis. In C. Drewienkiewicz, The potential use of erythropoietin to diminish the need for homologous blood in surgery (pp. 43-49). Medical Action Communication.

Elira-Dokekias, A., R'Zik, S., Beguin, Y., & Fillet, G. (1992). Monitoring of erythropoiesis by serum transferrin receptor levels in a case of chronic lymphocytic leukaemia and pure red cell aplasia treated with ciclosporin. Nouvelle Revue Française d'Hématologie, 34 (3), 257-8.

Beguin, Y., Yerna, M., Loo, M., Weber, M., & Fillet, G. (1992). Erythropoiesis in multiple myeloma: defective red cell production due to inappropriate erythropoietin production. British Journal of Haematology, 82 (4), 648-53. doi:10.1111/j.1365-2141.1992.tb06939.x

Grek, V., BEGUIN, Y., Weber, G., Sautois, B., PAQUOT, N., SCHEEN, A., Lefebvre, P., & FILLET, G. (1992). Acute functional iron deficiency in obese subjects during very-low-energy all- protein diet [Poster presentation]. 24th Congress of The International Society of Haematology, London, United Kingdom.

Beguin, Y., Clemons, G. K., Oris, R., & Fillet, G. (1991). Circulating erythropoietin levels after bone marrow transplantation: inappropriate response to anemia in allogeneic transplants. Blood, 77 (4), 868-73. doi:10.1182/blood.v77.4.868.bloodjournal774868

Beguin, Y., & Fillet, G. (1991). Erythropoïétine : utilisation diagnostique et thérapeutique. Revue de l'Association Belge des Technologues de Laboratoire, 18 (3), 161-168.

Collignon, J., Laurent, C., Rombout, S., & Fillet, G. (1991). L'examen cytogénétique en onco-hématologie : son importance dans la stratégie thérapeutique. Médecine et Hygiène, 49, 3411-3417.

Beguin, Y., Sautois, B., & Fillet, G. (1991). Perspectives diagnostiques et thérapeutiques de l'érythropoïétine. Médecine et Hygiène, 49, 2034-2045.

Sautois, B., Mélon, P., Grek, V., Fassotte, M.-F., & Fillet, G. (1991). Thrombocytopénie allergique à la nitrofurantoïne. Revue Médicale de Liège, 46, 592.

Beguin, Y., Lipscei, G., Thoumsin, H., & Fillet, G. (1991). Blunted erythropoietin production and decreased erythropoiesis in early pregnancy. Blood, 78 (1), 89-93. doi:10.1182/blood.v78.1.89.89

Grek, V., Andrien, F., Collignon, J., & Fillet, G. (1991). Allergic cross-reaction of teicoplanin and vancomycin. Journal of Antimicrobial Chemotherapy, 28, 476-477. doi:10.1093/jac/28.3.476

Beguin, Y., Loo, M., & Fillet, G. (1991). Le dosage du récepteur circulant de la transferringe : une nouveauté pour quantifier l'érythropoïèse. Médecine et Hygiène, 49, 2041-2045.

Beguin, Y., & Fillet, G. (1990). Erythropoietine: utilisation diagnostique et therapeutique. Revue Médicale de Liège, 45 (6), 261-7.

Andrien, F., Fassotte, M.-F., Beguin, Y., & Fillet, G. (1990). Traitement des lymphomes non hodgkiniens : de l'abstention thérapeutique à la greffe de moelle. Médecine et Hygiène, 48, 3672-3676.

Beguin, Y., Lipscei, G., Oris, R., Thoumsin, H., & Fillet, G. (1990). Serum immunoreactive erythropoietin during pregnancy and in the early postpartum. British Journal of Haematology, 76 (4), 545-9. doi:10.1111/j.1365-2141.1990.tb07914.x

Beguin, Y., Bours, V., Delbrouck, J.-M., Robaye, G., Roelandts, I., Fillet, G., & Weber, G. (1990). Use of PIXE to measure serum copper, zinc, selenium, and bromine in patients with hematologic malignancies. Nuclear Instruments and Methods in Physics Research. Section B, Beam Interactions with Materials and Atoms, B49, 202-204. doi:10.1016/0168-583X(90)90243-N

Beguin, Y., Fassotte, M.-F., Hay, F., Dokekias, A., Andrien, F., Bours, V., Moutschen, M., Runde, V., Bury, J., & Fillet, G. (1990). Greffes de moelle osseuse: bilan au CHU de Liege. Revue Médicale de Liège, 45 (6), 268-79.

Fassotte, M.-F., Beguin, Y., Andrien, F., & Fillet, G. (1990). Allogreffes et autogreffes de moelle osseuse. Indications, résultats, perspectives. Médecine et Hygiène, 48, 3666-3671.

Pierard, G., Pierard-Franchimont, C., Rurangirwa, A., Hermanns, G., Dokekias, A., de Beule, D., & Fillet, G. (1990). Trichosporonose des immunodéprimés. Annales de Dermatologie et de Vénéréologie, 117 (11), 856-8.

Triffaux, H., & Fillet, G. (1990). Rôle du volume globulaire moyen dans le diagnostic de l'anémie. Actualité Médicale Belge, 275, 8-9.

Beguin, Y., Bours, V., Delbrouck, J.-M., Robaye, G., Roelandts, I., & Fillet, G. (1990). Relationship of serum selenium to tumor activity in acute non lymphocytic leukemia (ANLL) and chronic lymohocytic leukemia (CLL). Metal ions in Biology and Medecine, 500-502.

Beguin, Y., Bours, V., Delbrouck, J. M., Robaye, G., Roelandts, I., Bury, J., Fillet, G., & Weber, G. (November 1989). Relationship of Serum Selenium Levels to Tumor Activity in Acute Non-Lymphocytic Leukemia. Carcinogenesis, 10 (11), 2089-91. doi:10.1093/carcin/10.11.2089

Fillet, G., Baldelli, L., & BEGUIN, Y. (1989). Model of reticuloendothelial iron metabolism in humans: abnormal behavior in idiopathic hemochromatosis and in inflammation. Blood, 74 (2), 844-51. doi:10.1182/blood.v74.2.844.bloodjournal742844

Beguin, Y., Fillet, G., Bury, J., & Fairon, Y. (1989). Ferrokinetic study of splenic erythropoiesis: relationships among clinical diagnosis, myelofibrosis, splenomegaly, and extramedullary erythropoiesis. American Journal of Hematology, 32 (2), 123-8. doi:10.1002/ajh.2830320209

Dokekias, A. E., Croisiaux, C., Andrien, F., Andre, C., Trotteur, G., Henrivaux, P., Gaspard, U., Rorive, G., & Fillet, G. (1989). Purpura thrombotique thrombocytopénique. Revue Médicale de Liège, 44, 601-609.

Fillet, G., & Beguin, Y. (1989). Reutilisation du fer dans l'organisme et regulation du fer de reserve. Interet du dosage du recepteur de la transferrine dans le plasma. Bulletin et Mémoires de l'Académie Royale de Médecine de Belgique, 144 (1-2), 113-8; discussion 118-20.

Grek, V., Hay, F., Beguin, Y., Andrien, F., Dokekias, A., & Fillet, G. (1989). La leucémie a tricholeucocyte: 30 ans après. Revue Médicale de Liège, 44 (10), 358-64.

Bury, J., Salmon, J., & Fillet, G. (1988). Gammapathie monoclonale d'origine indéterminée et myélome. Revue Médicale de Liège, 43, 270-274.

Bonnet, P., de Leval, J., Fillet, G., & Golaire, M. C. (1988). Plasmocytome solitaire de l'urètre. Acta Urologica Belgica, 51, 81-85.

Beguin, Y., & Fillet, G. (1988). Les états de surcharge en fer: hémosiderose et hémochromatose. Revue Médicale de Liège, 43 (8), 275-82.

Fillet, G., Bury, J., & Baudrihaye, M. (1987). Allogreffes et autogreffes de moelle osseuse. Principes et indications. Revue Médicale de Liège, 42, 503-509.

Fillet, G., Bury, J., Beguin, Y., Duvivier, A., Hoyoux, C., & Bours, V. (1987). Les cancers hématologiques en 1987. Chimiothérapie et immunothérapie. Revue Médicale de Liège, 42 (10), 496-502.

Andrien, F., Duvivier, A., Bury, J., Lemaire, M., Thiry, A., Boniver, J., & Fillet, G. (1987). Traitement des lymphomes non hodgkiniens. Revue Médicale de Liège, 42, 516-522.

Beguin, Y., Bury, J., Delbrouck, J. M., Fillet, G., Robaye, G., Roelandts, I., & Weber, G. (1987). Serum zinc and copper as prognostic factors in acute nonlymphocytic leukemia. Haematology and Blood Transfusion, 30, 380-4. doi:10.1007/978-3-642-71213-5_64

Beguin, Y., Weber, G., Delbrouck, J.-M., Robaye, G., Roelandts, I., Bury, J., & Fillet, G. (1987). Dosage du zinc sérique chez des patients atteints de leucémie aiguë. In A. Favier, J. Arnaud, ... H. Faure, Le zinc en médecine et biologie (pp. 224-226). Paris, France: Editions Médicales Internationales.

Beguin, Y., Delbrouck, J.-M., Robaye, G., Roelandts, I., Bury, J., Fillet, G., & Weber, G. (1987). Correlation of serum trace elements with other biological parameters in hemoproliferative disorders. Trace element analytical chemistry in medicine and biology, 4, 537-545.

Bury, J., Andrien, F., Baudrihaye, M., Beguin, Y., Duvivier, A., Hoyoux, C., Runde, V., & Fillet, G. (1987). Greffe de moelle: résultats préliminaires au CHU. Revue Médicale de Liège, 42 (10), 510-5.

Beguin, Y., Brasseur, F., Weber, G., Bury, J., Delbrouck, J.-M., Roelandts, I., Robaye, G., & Fillet, G. (1987). Observations of serum trace elements in chronic lymphocytic leukemia. Cancer, 60 (8), 1842-6. doi:10.1002/1097-0142(19871015)60:8<1842::AID-CNCR2820600828>3.0.CO;2-W

Beguin, Y., Boniver, J., Bury, J., Defraigne, J.-O., Detroz, B., Fillet, G., & Lejeune, G. (1987). Plasmacytoma of the thyroid: a case report, a study with use of the immunoperoxidase technique, and a review of the literature. Surgery, 101 (4), 496-500.

Fillet, G. (1987). Hématotoxicité médicamenteuse. Revue Médicale de Liège, 42, 919-920.

Ludwig, H., Cortelezzi, A., Scheithauer, W., Van Camp, B. G. K., Kuzmits, R., Fillet, G., Peetermans, M., Polli, E., & Flener, R. (1986). Recombinant Interferon alfa-2c versus polychemotherapy (VMCP) for treatment of multiple myeloma : a prospective randomized trial. European Journal of Cancer and Clinical Oncology, 22, 1111-1116. doi:10.1016/0277-5379(86)90015-5

Andrien, F., Lemaire, M., Beguin, Y., Bury, J., Closon, J., David, J.-L., Dejardin-Closon, M.-T., Duvivier, A., Fillet, G., & Tjean, M. (1986). Second tumors and myeloproliferative diseases after Hodgkin's disease treatment. Leukemia Research, 10, 887.

Beguin, Y., Weber, G., Delbrouck, J. M., Roelandts, I., Robaye, G., Bury, J., & Fillet, G. (1986). Serum trace elements during chemotherapy for acute myelogenous leukemia. Acta Pharmacologica et Toxicologica, 59 Suppl 7, 270-3. doi:10.1111/j.1600-0773.1986.tb02760.x

Fillet, G., & Bury, J. (1986). Cancers hématologiques et qualité de vie. Revue Médicale de Liège, 41, 673-674.

Beguin, Y., Bury, J., Fillet, G., & Lennes. (1985). Treatment of acute nonlymphocytic leukemia in young and elderly patients. Cancer, 56 (11), 2587-92. doi:10.1002/1097-0142(19851201)56:11<2587::AID-CNCR2820561109>3.0.CO;2-8

Lubrano, D., Helias, P., Bach, P., Leclercq, M., Fillet, G., Lecomte, J., & Damas, J. (1985). Un cas d'envenimation mortelle avec hyperfibrinolyse par piqûre multiples de guêpes (Vespa Crabro L.). Revue Médicale de Liège, 40, 844-846.

Malherbe, R., Bury, J., Fillet, G., Andrien, J.-M., & Borlee, M. (1985). Etude de cinq cas de leucémie à tricholeucocyte. Revue Médicale de Liège, 40, 586-592.

Beguin, Y., Detroz, B., Defraigne, J.-O., Bury, J., Boniver, J., Fillet, G., & Lejeune, G. (1985). Solitary plasmacytoma of the thyroid with serum monoclonal IgG. In J. Radl, W. Hijmans, ... B. Van Camp, Monoclonal gammopathies. Clinical significance and basic mechanisms (pp. 251-253). Eurage.

Fillet, G. (1984). Agranulocytose médicamenteuse. Médecine et Hygiène, 42, 2533-2541.

André, C., Bury, J., Fillet, G., & Moonen, G. (1984). A rare complication of ophtalmic zona: spreading cerebral arteritis. Acta Clinica Belgica, 39 (3), 159-162.

Fillet, G. (1984). Les leucémies - Chronique interuniversitaire. Revue Médicale de Liège, 39, 781-787.

André, C., Bury, J., Fillet, G., & Moonen, G. (1984). Une complication rare du zona ophtalmique : l'artérite cérébrale de propagation. Acta Clinica Belgica, 39, 159-162.

Fillet, G. (1984). Les leucémies - Chronique interuniversitaire. Louvain Medical, 103, 437-445.

Fillet, G., & Bury, J. (1983). Système HLA et greffe de moelle osseuse. Revue Médicale de Liège, 38, 135-136.

Henrivaux, P., Bury, J., Demonty, J., & Fillet, G. (1983). Le syndrome d'immunodéficience acquise : espoirs et limites thérapeutiques. Médecine et Hygiène, 41, 4269-4273.

Bury, J., & Fillet, G. (1983). Ciclosporine et immunosuppression. Applications actuelles. Médecine et Hygiène, 41, 2696-2701.

Tjean, M., Bury, J., & Fillet, G. (1982). La vidarabine : un traitement antiherpétique actif par voie parentérale. Revue Médicale de Liège, 37, 82-85.

Bury, J., Fillet, G., Hugues, J., & Nizet, C. (1982). Les signes prémonitoires des hémopathies malignes. Revue Médicale de Liège, 37, 293-296.

Fillet, G., & Bury, J. (1982). Thérapeutique antivirale systémique : vidarabine et acyclovir. Médecine et Hygiène, 40, 2729-2734.

Fillet, G., Desoignies, J., Jardon-Jeghers, C., & Boniver, J. (1982). Lymphome centrocytique-centroblastique ou est-il bon, est-il méchant ? Revue Médicale de Liège.

Fillet, G. (1982). Les leucémies chroniques. Aspects cliniques et thérapeutiques. Actualité Médicale Belge, 9, 14-15.

Delvaux, D., Andrien, J.-M., & Fillet, G. (1981). Le traitement par chélateurs de l'hémochromatose post-transfusionnelle. Revue Médicale de Liège, 36, 477-479.

Fillet, G. (1980). Les fièvres prolongées d'origine néoplasique. Revue Médicale de Liège, 35, 190-193.

Radermecker, M., Bruwier, M., Bury, J., & Fillet, G. (1980). P1 incompatibility in pigeon breeders. Clinical Allergy, 10, 309-312. doi:10.1111/j.1365-2222.1980.tb02112.x

Fillet, G. (1980). Diagnostic et traitement des maladies de surcharge en fer. Médecine et Hygiène, 38, 2662-2667.

Fillet, G. (1978). Le myélome. Revue Médicale de Liège, 33, 354-364.

Fillet, G. (1978). Le cycle du fer. Physiopathologie et exploration. Annales Médico-chirurgicales du Hainaut, 30, 247-259.

Fillet, G., Andrien, J.-M., & Bury, J. (1977). Effects of transfusion on serum iron, serum lactate dehydrogenase and platelets in megaloblastic anemia. American Journal of Clinical Pathology, 68, 458-462. doi:10.1093/ajcp/68.4.458

Andrien, J.-M., Bury, J., Fillet, G., Hugues, J., & Paulus, J.-M. (1975). Diagnostic et traitement des anémies. Revue Médicale de Liège, 30, 285-294.

Fillet, G., Cook, J.-D., & Finch, C. A. (1974). Storage Iron Kinetics. VII. A biologic Model for Reticulo-Endothelial Iron Transport. Journal of Clinical Investigation, 53, 1527-1533.

Cook, J. D., Barry, W. E., Hershko, C., Fillet, G., & Finch, C. A. (1973). Iron Kinetics with emphasis on Iron overload. American Journal of Pathology, 72, 337-343.

Fillet, G. (1972). Utilisation en scintillation liquide du Triton X-100 pour le comptage à haut rendement du radiofer plasmatique. Pathologie Biologie, 20, 227-230.

de Leval, M., Fourny, J., Fillet, G., & Honoré, D. (1971). Haematological modifications in counterpulsation. Cardiovascular Surgery, 12, 210-217.

Biver, A., Fillet, G., & Demelenne, A. (1971). Une étude des staphylocoques coagulase positifs isolés à partir de grands brûlés. Acta Chirurgica Belgica, 70 (8), 696-711.

Fillet, G., & Paulus, J.-M. (1971). Tests isotopiques en Hématologie. Revue Médicale de Liège, 26 (5), 156-166.

Fillet, G., Hanquet, M., & Castermans, A. (1969). A study of Staphylococcus Aureus infection in burns. Verbrennungskrankheit Fortschritte in Klinik und Forschung, 171-177.

Paulus, J.-M., Fillet, G., Thompson, K., & Willems, J. (1969). Interprétation mathématique de l'étude de la durée de vie des plaquettes marquées au chrome radio-actif. Nouvelle Revue Française d'Hématologie, 9 (6), 886-888.

Fillet, G. (1968). Anémie ferriprive - Métabolisme du fer - Traitement martial. Revue d'enseignement post-universitaire de la Société de Médecine de Charleroi, 58-61.